Peer-Reviewed Journal Articles
1. Suwanvecho, S., Shortliffe, E. H., Suwanrusme, H., Issarachai, S., Jirakulaporn, T., Taechakraichana, N., Lungchukiet, P., Thanakarn, N., Decha, W., Boonpakdee, W., Wongattananon, P., Preininger, A., Keyaert, S., Dankwa-Mullan, I., Esquivel, J., Patel, V. L., Jackson, G., & Kiatkijarornthada, N. (2019). A blinded evaluation of a clinical decision-support system at a regional cancer care center. Journal of Clinical Oncology, 37(15_suppl), 6553. https://doi.org/10.1200/jco.2019.37.15_suppl.6553
2. Suwanvecho, S., Suwanrusme, H., Jirakulaporn, T., Lungchukiet, P., Thanakarn, N., Decha, W., Boonpakdee, W., Wongattananon, P., Preininger, A. M., Solomon, M., Wang, S., Hekmat, R., Esquivel, J., Dankwa-Mullan, I., Patel, V. L., Shortliffe, E., Arriaga, Y. E., Jackson, G. P., & Kiatkijarornthada, N. (2020). Associations between concordance with oncology clinical decision support and clinical outcomes in lung cancer patients. Journal of Clinical Oncology, 38(15_suppl), e14114. https://doi.org/10.1200/jco.2020.38.15_suppl.e14114
3. Suwanvecho, S., Suwanrusme, H., Jirakulaporn, T., Issarachai, S., Taechakraichana, N., Lungchukiet, P., Decha, W., Boonpakdee, W., Thanakarn, N., Wongattananon, P., Preininger, A. M., Solomon, M., Wang, S., Hekmat, R., Dankwa-Mullan, I., Shortliffe, E., Patel, V. L., Arriaga, Y., Jackson, G. P., & Kiatkijarornthada, N. (2021). Comparison of an oncology clinical decision-support system’s recommendations with actual treatment decisions. Journal of the American Medical Informatics Association, 28(4), 832–838. https://doi.org/10.1093/jamia/ocaa334
4. Suwanvecho, S., Suwanrusme, H., Jirakulaporn, T., Taechakraichana, N., Lungchukiet, P., Thanakarn, N., Decha, W., Boonpakdee, W., Wongattananon, P., Preininger, A., Dankwa-Mullan, I., Solomon, M., Wang, S., Jackson, G., Patel, V., Shortliffe, E., & Kiatkijarornthada, N. (2019). A blinded comparison of patient treatments to therapeutic options presented by an artificial intelligence-based clinical decision-support system. Annals of Oncology, 30, v583. https://doi.org/10.1093/annonc/mdz257.030
5. Suwanvecho, S., Suwanrusme, H., Issarachai, S., Jirakulaporn, T., Taechakraichana, N., Lungchukiet, P., Thanakarn, N., Decha, W., Boonpakdee, W., Wongattananon, P., Preininger, A., Arriaga, Y. E., Solomon, M., Wang, S., Dankwa-Mullan, I., Esquivel, J., Jackson, G., Patel, V. L., Shortliffe, E., & Kiatkijarornthada, N. (2019). Concordance between a clinical decision-support system and treatments selected by clinicians as a function of cancer type or stage. Journal of Global Oncology, 5(suppl), 95. https://doi.org/10.1200/jgo.2019.5.suppl.95
Clinical Trial Leadership
• Randomized Phase III multinational trial: Bevacizumab with Capecitabine and Oxaliplatin for colorectal cancer
• Expanded access program coordination for Tarceva (Erlotinib) in advanced non-small cell lung cancer
• Multi-center Phase III study assessing Gefitinib versus Carboplatin/Paclitaxel as first-line treatment for advanced non-small cell lung cancer in Asia